NLS Acquisition

Acquisition - January 9, 2023

AstraZeneca to acquire CinCor Pharma

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition will bolster AstraZeneca’s cardiorenal pipeline by adding CinCor’s candidate drug, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure lowering […]

Acquisition - December 12, 2022

SynAct acquires TXP Pharma and carries out a directed share issue

SynAct Pharma has entered into a conditional agreement on acquisition of TXP Pharma, a Swiss-incorporated biotech company researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The purchase price consists of a fixed purchase price of SEK 136 million and a potential additional purchase price of SEK 55 million, where the […]

Acquisition - December 2, 2022

AstraZeneca to acquire Neogene Therapeutics

AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company focusing on the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts) that offer a novel cell therapy approach for targeting cancer. With a shared goal of bringing cell therapies to patients with solid tumors, Neogene’s expertise in TCR-T discovery, […]

Acquisition - October 31, 2022

Curida acquires biologics manufacturer Diatec

Through the acquisition of Norwegian company Diatec, Curida takes the first steps into biological production. The acquisition strengthens the base on which Curida aims to grow further in the international CDMO market, it states. Before the acquisition, Curida provides manufacturing and development services out of two sites in Norway, and exports to more than 80 […]

Acquisition - October 14, 2022

Cytel acquires SDS Life Science and SDS MedteQ

The US company has announced an agreement to acquire SDS Life Science AB and SDS MedteQ AB. With SDS Life Science and SDS MedteQ supporting more than 100 biomedical sponsors in Scandinavia, in addition to several multinational pharmaceutical companies, the acquisition continues Cytel’s rapid growth into new global markets, the company states in a press […]

Acquisition - September 5, 2022

Center for Translational Research acquires Admescope’s Swedish operation

Center for Translational Research AB acquires Admescope’s Swedish operation (changing name to Metasafe) and strengthens collaboration with Admescope and Symeres. Center for Translational Research CTR is a group of complementary life science service companies providing expert services and advice within product development. The services provided by Admescope Sweden/Metasafe complements well the current offerings and will […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.